Roche Ends 2011 as the Leading Big Pharma Dealmaker
By Heather Cartwright
PharmaDeals Corp-METRx: Vol 2011 Issue 6 (Table of Contents)
Published: 28 Dec-2011
DOI: 10.3833/pdcmx.v2011.i6.1642 ISSN: 2047-7007
Section: Quarterly Review
Fulltext:
Abstract
The PharmaDeals Corp-METRx Deal Activity League Table remains unchanged in December 2011 and thus Roche ends the year ahead of its peer group in term of total deal activity, even when this is adjusted relative to 2010 sales and 5-year patent risk
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018